A drug developed to treat diabetes may offer a new approach to Alzheimer’s disease


Diabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, have become popular among celebrities and investors and currently address some of the most difficult-to-treat brain diseases, including Alzheimer’s disease. being studied for

Researchers say that from Ozempic to older mainstream diabetes treatments like insulin and metformin, they seem to address different aspects of Alzheimer’s disease’s metabolism, including a protein called amyloid and inflammation. It says.

By improving glucose use and reducing inflammation throughout the body, including the brain, it is hoped that the progression of debilitating diseases such as Alzheimer’s and Parkinson’s can be slowed.

In an age of misinformation and information overload, Quality journalism is more important than ever.
By subscribing, you can get the story right.

subscribe now



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *